Funding Wrap of the Week | American Startups Funding Roundup | June 24 – June 28

There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals of this week. Let’s talk about the Top 10 Funding deals. 

The Top 10 American Startups Funding Deals

Formation Bio

Formation Bio, a tech-driven and AI-native pharma company has raised $372M Series D funding led by a16z with significant participation from Sanofi. Current investors also joined the round, including Sequoia, Thrive, Emerson Collective, and Lachy Groom, along with new investors, such as SV Angel Growth and FPV Ventures. 

Founded 2023, Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. 

Elsewhere Partners

Elsewhere Partners announced the closing of Elsewhere Partners III, L.P. (EP Fund III), with $285 million in additional capital focused on majority investments in growth-ready B2B software companies.

Elsewhere Partners, a tech-focused private equity firm, invests in growth-ready lower middle market software companies around the globe.

Foodsmart

The Rise Fund, the multi-sector strategy of TPG’s global impact investing platform, today announced it has signed definitive documentation to lead an investment of over $200 million in Foodsmart, the leading telenutrition provider and food benefits management platform in the US.

Foodsmart, is the largest telenutrition and food benefits management platform—aka “Foodcare”—in the US, backed by the largest national network of Registered Dietitians.

Create Music Group

Create Music Group, a rapidly growing music and entertainment company, announced today a $165 million investment led by private equity investment firm Flexpoint Ford. 

Create Music Group is a leading music and entertainment company. The company operates as a record label, distribution company, and entertainment network which generates over 15 billion music streams each month on DSP’s. 

NeueHealth

NeueHealth, the value-driven healthcare company, raises loan facility for up to $150 million funding Hercules Capital.

NeueHealth is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors.

Bright Machines

Bright Machines, an innovator in intelligent, software-defined manufacturing, has raised $126M in Series C funding, with $106M in equity led by investment from funds and accounts managed by BlackRock and participation from NVIDIA, Microsoft, Eclipse, Jabil and Shinhan Securities, and with $20M in venture debt from J.P. Morgan. 

Bright Machines is an industry-leading software and robotics company that offers a full-stack automation solution for manufacturing. Bright Machines’ flexible automated assembly specializes in building the AI backbone — AI hardware infrastructure.

Endogenex

Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes, announced it has closed an oversubscribed Series C financing totaling $88 million.

Endogenex, founded in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). The company’s innovations focus on resetting the body’s metabolic signaling system by harnessing its natural regenerative capabilities to improve metabolic function. 

Odaseva

Odaseva, the leading enterprise data security platform for Salesforce, announced a $54 million Series C equity financing, bringing the total company funding to more than $90 million.

Odaseva delivers the strongest data security solution for enterprises running on Salesforce, safeguarding confidentiality and integrity of critical business information. 

UroMems

UroMems, a global company developing innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI), secures $47million in series C round funding the largest fundraising round to date for the company.

UroMems is developing breakthrough, automated technology to treat stress urinary incontinence (SUI) providing an improved quality of life for women and men. UroMems’ innovative technology platform is transforming the industry with ease of use through smart active implants.

Route

Route, on a mission to connect the world’s commerce has secured $40M Series C Funding to the business to help us achieve that mission.

Route was founded in 2019 from a vision to provide exceptional experiences to shoppers. founder, Evan Walker, recognized the need for something better: a way to protect packages on their journey that would give confidence to the brands and their customers.

Frequently asked questions (FAQs)